May 15 (UPI) --Treatment with the hepatitis drug interferon-alpha-2b might speed recovery for people with COVID-19, a small study published Friday by the journal Frontiers in Immunology found.
The infant's mother was initially evaluated in St. Louis Children's Hospital at 10 years of age with acute onset chorea, splenomegaly and thrombocytosis (platelet count of 1.5 million/cumm). Her ...
Interferon alfa-2b (IFN alpha-2b) exhibits antitumor activity in metastatic melanoma and on this basis has been evaluated as an adjuvant therapy following surgery for deep primary (T4) or regionally ...
The COMBI study, a prospective, open‐label, single‐arm phase 2 study ongoing in Denmark, is investigating the feasibility of treating patients with low- to intermediate-risk myelofibrosis ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...
Twenty-four patients with human papillomavirus (HPV)-associated cervical intraepithelial neoplasia (CIN); of whom 13 had CIN 1, 8 had CIN 2, and 3 had CIN 3; were treated with recombinant alpha 2b ...
Please provide your email address to receive an email when new articles are posted on . The addition of interferon alfa to temozolomide significantly extended survival among patients with newly ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results